• Exchange: LSE EuropeQS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech


78.340 EUR 0.405 0.52%

As of 10:54:03 ET on 12/19/2014.

Snapshot for Merck KGaA (MRK)

Open: 78.730 Day's Range: 77.525 - 79.705 Volume: 8,257
Previous Close: 77.935 52wk Range: 56.438 - 91.645 1-Yr Rtn: +23.47%

Stock Chart for MRK

No chart data available.
  • MRK:LI 78.135
  • 1D
  • 1M
  • 1Y
Interactive MRK Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MRK

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 16.8836
Relative P/E vs. UKX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 4.6400
Est. PEG Ratio 2.6405
Market Cap (M EUR) 34,100.06
Shares Outstanding (M) 129.24
30 Day Average Volume 25,838
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.21%
Cash Dividend (EUR) 0.9500
Dividend Ex-Date 05/12/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MRK

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for MRK

Merck KGaA is a global pharmaceutical and chemicals company. The Company researches drugs in the areas oncology and neurodegenerative as well as autoimmune and inflammatory diseases. Also, it markets cardiovascular, fertility, endocrinology, and over-the-counter products as well as products for flat screens and the pharmaceutical, food, cosmetics, packaging, and coatings.

Karl-Ludwig KleyChairman-Mgmt Board/CEOMarcus KuhnertCFO/Member-Exec Board
Kai BeckmannChief Administration OfficerBernd ReckmannCEO:Chemicals
More Company Profile & Key Executives for MRK

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil